Lawrence Charnas
10Patents
4h-index
25Co-inventors
56Inventor score
Filing activity: Jun 25, 2011 → Aug 16, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9283181B2 | CNS delivery of therapeutic agents | Chemistry; Metallurgy | 18 | Active |
| US8945542B2 | Methods for treating lysosomal acid lipase deficiency | Human Necessities | 7 | Active |
| US10456454B2 | CNS delivery of therapeutic agents | Chemistry; Metallurgy | 6 | Active |
| US9770410B2 | Methods and compositions for CNS delivery of arylsulfatase A | Human Necessities | 6 | Active |
| US10660944B2 | Stable formulations for CNS delivery of arylsulfatase A | Chemistry; Metallurgy | 3 | Active |
| US9957324B2 | Anti-FLT-1 antibodies in treating duchenne muscular dystrophy | Chemistry; Metallurgy | 2 | Active |
| US11471516B2 | CNS delivery of therapeutic agents | Chemistry; Metallurgy | 1 | Active |
| US12409210B2 | CNS delivery of therapeutic agents | Chemistry; Metallurgy | 0 | Active |
| US10646554B2 | Methods and compositions for CNS delivery of arylsulfatase A | Chemistry; Metallurgy | 0 | Active |
| US12168041B2 | Methods and compositions for CNS delivery of arylsulfatase A | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.